| abstract |
[Objective] To provide a novel inflammatory disease improving agent. An inflammatory disease ameliorating agent preferably comprising a selenocysteine-containing protein exemplified by selenoprotein P, a C-terminal peptide of the protein or a group of the peptides as a main active ingredient. [Effect] For example, a suitable ameliorating agent for inflammatory diseases caused by various etiologies involving interleukin-6 production is provided. [Selection diagram] None |